Lantern Pharma’s $69.0M Follow-on Public Offering

Blank Rome LLP advised Think Equity on the deal. Think Equity acted as representative of the underwriters in connection with a $69.0M follow-on public offering of…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here